World of DTC Marketing

JUNE 6, 2025

With reports of budget constraints and layoffs hitting federal agencies like the FDA and CDC, many talented public health professionals are suddenly finding themselves out of work. As they look to the private sector—particularly the pharmaceutical and biotech industries—the question arises: do they possess the right business skills to make a successful transition ?

Pharma 244

Pharma FDA Ethics Government 244

Fierce Pharma

JUNE 6, 2025

In late April, when Sanofi revealed that it was selling a controlling stake in its consumer health business Opella for 10 billion euros, chief financial officer Francois Roger said that the French drugmaker would “explore external growth opportunities for bolt-on acquisitions.” Just five weeks later, Sanofi has made a deal few would describe as “bolt-on,” as it has bought out Blueprint Medicines for $9.5 billion.

Medicine 204

Medicine 204

PharmaVoice

JUNE 6, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Pharma 130

Pharma Leads Patients Side effects 130

Fierce Pharma

JUNE 6, 2025

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu looks poised to reach newly diagnosed patients, with efficacy data that live up to the pair’s previous “highly statistically significant” description.

Patients 193

Patients 193

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

JUNE 6, 2025

In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary. The post Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs appeared first on MedCity News.

Patients 147

Patients 147

MedCity News

JUNE 6, 2025

When an attack or other issue occurs, the main difference between being down for months versus minutes or a day is having a mature and tested incident response plan. Without a plan, your cybersecurity team is flying blind, resulting in confusion and inefficiency that significantly slows your response time. The post How Healthcare Can Reduce Cybersecurity Response Times from Hours to Minutes appeared first on MedCity News.

Healthcare 165

Healthcare Healthcare 165

Fierce Pharma

JUNE 6, 2025

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Pharma 189

Pharma Marketing 189

MedCity News

JUNE 6, 2025

Hospitals saw improved financial performance during the first four months of the year, with operating margins rising to 3.3% thanks to higher patient volumes and more efficient throughput. However, experts warn that hospitals remain financially vulnerable as non-labor expenses continue to rise. The post Hospitals See Financial Gains Due to Higher Volumes & Improved Throughput appeared first on MedCity News.

Patients 208

Patients 208

Fierce Pharma

JUNE 6, 2025

Novartis has submitted a request in Delaware federal court urging the judge who oversaw a December patent litigation trial to issue a final decision and verdict on the case before July 15. If it gets its way, Novartis could block generic rival MSN from launching its Entresto copycat until late next year.

171

171

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

MedCity News

JUNE 6, 2025

The case for modernization isn’t solely about improving efficiency. It’s about equipping hospitals with the resources necessary to manage risk proactively, respond to negative trends quickly, and prioritize patient safety with high reliability. The post The Hidden Cost of Disconnected Quality Systems: Why Hospitals Should Modernize Now appeared first on MedCity News.

Safety 165

Safety Management Patients Physicians 165

Fierce Pharma

JUNE 6, 2025

DeepIntent’s Jay Richetelli discusses the role of AI, data ownership and trust in shaping the next era of pharma marketing

Pharma 164

Pharma Marketing 164

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Food and Drug Administration 81

Food and Drug Administration Media Pharmaceutical Manufacturing 81

Fierce Pharma

JUNE 6, 2025

Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, scoring an FDA approval to expand its use to all patients with metastatic castration-sensitive prostate cancer, with or without added chemotherapy.

Sales 164

Sales FDA Patients 164

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

European Pharmaceutical Review

JUNE 6, 2025

New positive interim trial data has demonstrated that a potential best-in-class gene therapy can provide meaningful functional improvements in Duchenne muscular dystrophy. These new findings are from the Phase I/II AFFINITY DUCHENNE clinical trial for RGX-202. With a differentiated microdystrophin construct, the treatment can encode key regions of naturally occurring dystrophin, including the C-Terminal (CT) domain.

Safety 52

Safety Leads Medical Pharmaceutical 52

Fierce Pharma

JUNE 6, 2025

In the study, diabetes patients who took GLP-1s were twice as likely to develop neovascular age-related macular degeneration (nAMD) than those without GLP-1 exposure.

Patients 217

Patients 217

European Pharmaceutical Review

JUNE 6, 2025

The global cell therapy market is projected to reach $20.07 billion by 2030, driven by the rising demand for off-the-shelf therapies that offer scalable, standardised solutions for treating a wide range of diseases, including cancer and auto-immune diseases. 1 One promising approach involves natural killer (NK) cells derived from induced pluripotent stem cells (iPSCs) which provide a renewable, genetically stable cell source capable of precise engineering for enhanced therapeutic functionality.

Engineering 52

Engineering Manufacturing Media Distribution 52

Fierce Pharma

JUNE 6, 2025

Theravance estimates that its lifetime earnings from GSK's inhaler Trelegy, born out of a 2002 collab, total $1.52 billion.

144

144

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Media 52

Media Pharmaceutical Manufacturing Marketing 52

Fierce Pharma

JUNE 6, 2025

The Council of the European Union has delivered its newest set of proposals meant to shake up European pharma regulations and sharpen its competitive edge, but the plan isn't exactly what EU drugmakers had hoped for.

Competition 150

Competition Pharma 150

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Pharma 52

Pharma Manufacturing Media Pharmaceutical 52

Fierce Pharma

JUNE 6, 2025

Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the needle in resected skin cancer.

148

148

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Media 52

Media Pharmaceutical Manufacturing Government 52

Fierce Pharma

JUNE 6, 2025

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. AstraZeneca and Daiichi Sankyo trotted out Enhertu's detailed data in first-line breast cancer. Regeneron signed on a GLP-1/GIP candidate from Hansoh Pharma. And more.

Pharma 162

Pharma 162

Pharmacy Times

JUNE 6, 2025

Juan Ovalles, MD, PhD, discusses how high placebo response rates driven by background therapy complicate lupus drug trials, and outlines evolving strategies in trial design, clinical practice, and pharmacist-led care to ensure investigational biologics are fairly evaluated and appropriately used in systemic lupus erythematosus.

47

47

Fierce Pharma

JUNE 6, 2025

Johnson & Johnson’s Akeega is giving the PARP inhibitor class a first win in castration-sensitive prostate cancer, although the drug’s benefit in a patient subgroup remains unclear.

Patients 112

Patients 112

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Commerce

JUNE 6, 2025

In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s data reveals about the relationship between pharmacy access and broader health disparities in underserved communities.

Pharma 52

Pharma 52

Fierce Pharma

JUNE 6, 2025

PharmaForceIQ’s Stephen Onikoro explains why data, AI and real-time insights are redefining pharma marketing—and what teams must do to stay ahead.

Pharma 100

Pharma Marketing 100

Scott Burrows

JUNE 6, 2025

As a healthcare professional, you’re the heartbeat of hope in a world of chaos—saving lives, comforting families, and pushing through exhaustion. But when burnout dims your spark, how do you keep going? My name is Scott Burrows, and I’ve faced that question myself. After a kickboxing championship victory, a car accident on St. George’s Island left me paralyzed, shattering my dreams as a star wide receiver for Florida State University and a black-belt martial artist.

Healthcare 52

Healthcare Healthcare Management Training 52